2018
DOI: 10.1007/s13239-018-00378-y
|View full text |Cite
|
Sign up to set email alerts
|

Inter-Laboratory Characterization of the Velocity Field in the FDA Blood Pump Model Using Particle Image Velocimetry (PIV)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 27 publications
0
27
0
Order By: Relevance
“…The International Journal of Artificial Organs 44 (11) It should also be pointed out that this study only concerned the impact of turbulence models on the prediction of flow field. Blood damage such as hemolysis and thrombosis formation are more important issues for blood pumps.…”
Section: Declaration Of Conflicting Interestsmentioning
confidence: 99%
See 3 more Smart Citations
“…The International Journal of Artificial Organs 44 (11) It should also be pointed out that this study only concerned the impact of turbulence models on the prediction of flow field. Blood damage such as hemolysis and thrombosis formation are more important issues for blood pumps.…”
Section: Declaration Of Conflicting Interestsmentioning
confidence: 99%
“…[6][7][8][9][10] Moreover, U. S. Food and Drug Administration (FDA) has plans to use computational simulations as part of its medical device approval process to fully evaluate the safety of medical devices. 11 In recent years, FDA launched the round robin initiative and designed two benchmarks, the "idealized medical device" and "blood pump," to evaluate and verify the accuracy of CFD simulation and prediction of blood damage, with both flow field and hemolysis were measured. 11,12 Overall, the CFD results were quite different from the experiment, while some of the predicted hemolysis levels were even several orders of magnitude different from the experimental values.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Returning to the theme of inter-laboratory comparisons, our special issue includes three papers arising from the FDA's Critical Path Initiative for CFD. The first paper, by Hariharan et al, 20 focuses on a centrifugal blood pump model developed by the FDA for the ultimate purpose of validating CFD predictions of hemolysis in medical devices. Here the authors report the results of a round-robin comparison of particle imaging velocity (PIV) measurements, since PIV will, ultimately, serve as the reference standard against which CFD velocity predictions must be validated.…”
mentioning
confidence: 99%